Track the Cardiol Therapeutics Inc. stock price and the full management transaction log of the company, a listed equity based in Canada. Shares are quoted on the CA market, under the authority of SEDI. Market capitalisation: €315.4m. The latest transaction was reported on 30 August 2026 (57 - Exercise of rights). Among the most active insiders: Hamer, Andrew Warwick. The full history is accessible without an account.
9
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Cardiol Therapeutics Inc. Strong Buy (bullish), based on 2 analysts. Average price target: CA$6.00.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Cardiol Therapeutics Inc. is a biopharmaceutical company focused on developing therapies for cardiovascular diseases. It is listed on the Toronto Stock Exchange under the symbol XTSE.